Revenue
2019
2020
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | $44,288 | $26,064 |
| Gross profit | — | — | — | — | — | $8,886 | $3,128 |
| Gross margin | — | — | — | — | — | 20.06% | 12.00% |
| Research & development | — | — | $0 | $9,500 | $0 | — | — |
| Operating expenses | $34,659 | $43,158 | $30,500 | $48,568 | $54,296 | $99,352 | $11,128 |
| Operating income | −$34,659 | −$43,158 | −$30,500 | −$48,568 | $114,323 | −$90,466 | −$8,000 |
| Operating margin | — | — | — | — | — | −204.27% | −30.69% |
| EBITDA | −$34,659 | −$43,158 | −$24,533 | −$48,568 | — | — | — |
| Net income | −$42,124 | −$47,225 | −$32,060 | −$49,273 | $59,545 | −$91,852 | −$8,000 |
| Net profit margin | — | — | — | — | — | −207.40% | −30.69% |
| Basic EPSper basic share | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | -$0.01 | $0.00 |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | — | -$0.01 | $0.00 |
Reported shareholders